The author is a Reuters Breakingviews columnist. The opinions expressed are her own.
from Financial Regulatory Forum:
By Lawrence Hsieh, Practical Law
Although the pharmaceutical industry has drawn a lot of the attention given to corporate inversions, the regulatory environment for these tax-saving corporate relocation transactions also affects insurance mergers.